Highlights Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Delayed Canadian Securities Exchange Other stock markets 14:30:00 17/05/2024 BST			5-day change	1st Jan Change
0.04 ^CAD	0.00%		+14.29%	+33.33%

05-15	Diagnamed Holdings Corp. announced that it expects to receive CAD 0.65 million in funding	CI
04-25	Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Diagnamed?s Brain Age® Brain Health Ai Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper	04-25	CI
DiagnaMed Holdings Corp. Announces Canadian Launch of BRAIN AGE® Brain Health AI	04-23	CI
Diagnamed Holdings Corp. Adds New Launch Site of CERVAI Brain Health AI	04-03	CI
DiagnaMed Announces BRAIN AGE Trademark Registration Approved by CIPO	03-20	MT
DiagnaMed Holdings Corp. Announces Brain AGE Trademark Registration Approved by Canadian Intellectual Property Office	03-20	CI
DiagnaMed Holdings Corp. Accelerates Commercialization Initiatives of CERVAI Brain Health AI Solution	03-11	CI
Diagnamed Holdings Corp. Reports Earnings Results for the First Quarter Ended December 31, 2023	03-01	CI
DiagnaMed Announces Test Launch of CERVAI Brain Health in University Brain Health Center	02-28	CI
Diagnamed Holdings Corp. Reports Earnings Results for the Full Year Ended September 30, 2023	01-30	CI
Diagnamed Holdings Corp. Announces Pilot Launch of Cervai? Brain Health Ai Solution	01-17	CI
DiagnaMed Accelerates Commercialization of CERVAI(TM) Brain Health AI Platform with Acceptance into the SOPHIE Program	11-15	CI
DiagnaMed Holdings Corp. Launches New Healthcare Provider Network Program for CERVAI?? Brain Health AI Platform in Canada and the USA	03/10/23	CI
DiagnaMed Provides Update for its Brain Health AI Platform	13/09/23	MT
DiagnaMed Holdings Corp. Provides Update for its Brain Health AI Platform, CERVAI	13/09/23	CI
Diagnamed Holdings Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	24/08/23	CI
DiagnaMed Provides Update on CERVAI, a Brain Health AI Platform	20/06/23	MT
DiagnaMed Provides Update on CERVAIâ„¢, a Brain Health AI Platform Leveraging Generative AI	20/06/23	CI
DiagnaMed Holdings Corp. Launches A Generative Artificial Intelligence Medical Chatbot, Dr. GenAI	15/06/23	CI
DiagnaMed Holdings Corp. Launches FormGPT.io, a Generative AI Healthcare Solution	11/06/23	CI
DiagnaMed Holdings Corp. Launches PalGPT.ai, a Generative AI Brain Health Solution	25/05/23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Highlights

Filters